Price $0.78 |
Market Cap
89.4M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
3.57
|
P/S
42.83
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-62.7K
|
FCF
-0.7
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-155.10%
|
ROI
-74.70%
|
|
ROA
-99.10%
|
EPS Growth
-90.80%
|
Current Ratio
7.7
|
Debt/Equity
33.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Harvard Bioscience, Inc. (HBIO) | $7.01 | - | - | 284.5M | Strong Buy |
| Generex Biotechnology Corporat (GNBT) | $0.15 | - | - | 22.7M | Strong Buy |
| Pieris Pharmaceuticals Inc (PIRS) | $4.57 | - | - | 344.9M | Strong Buy |
| Sensus Healthcare Inc (SRTS) | $3.93 | - | - | 59.8M | Strong Buy |
| Fuse Medical Inc (FZMD) | $0.72 | - | - | 37.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
